Stams Diagnostics

    OverviewSuggest Edit

    Stams Diagnostics is a company that develops a contrast agent for early detection of colon cancer. It creates nanoparticles for specific targeting, cell uptake and emission of a strong fluorescence.
    TypePrivate
    Founded2019
    Websitestams-diagnostics.com

    Latest Updates

    Employees (est.) (Mar 2020)3

    Stams Diagnostics Financials and Metrics

    Summary Metrics

    Founding Date

    2019
    Show all financial metrics

    Stams Diagnostics Online and Social Media Presence

    Embed Graph

    Stams Diagnostics Frequently Asked Questions

    • When was Stams Diagnostics founded?

      Stams Diagnostics was founded in 2019.

    • How many employees does Stams Diagnostics have?

      Stams Diagnostics has 3 employees.

    • Who are Stams Diagnostics competitors?

      Competitors of Stams Diagnostics include G1 Therapeutics, Janssen Pharmaceuticals and PDL BioPharma.